Medical Outcomes Research & Evidence in Mesothelioma
DaSH Global in collaboration with Mesothelioma UK have undertaken a prospective cross-sectional study in the UK collecting both Clinical and Patient Reported Outcomes data from a total of 503 Mesothelioma patients.
The study recruited patients via a national network of 26 Mesothelioma Cancer Nurse Specialists and received audit approval from 18 NHS Regional Trusts.
Data collected from this study is now available for research requests. Please contact andrew@dash-global.com or lee@dash-global.com.